Aclarion director awarded 20,000 RSUs

Deitsch Stephen reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Deitsch Stephen reported acquisition or exercise transactions in this Form 4 filing.

Aclarion, Inc. director Stephen Deitsch received an equity grant of 20,000 restricted stock units (RSUs). The award was granted on 6/11/2026 under Aclarion's equity incentive plan at no cash cost per unit, with each RSU representing the right to receive one share of common stock.

According to the terms, 100% of the RSUs will vest on 6/1/2027, and any unvested RSUs will fully vest if there is a change of control as defined in the company’s equity incentive plan. Following this grant, Deitsch holds 20,000 shares/units directly.

Insider Trade Summary

Grant/Award: 20,000 shares

Grant/Award 1 txn

Insider Deitsch Stephen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,000 shares (Direct)

Footnotes (2)

1. F1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock.
2. F2. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

Key Figures

RSUs granted: 20,000 units Grant price: $0.00 per unit Vesting date: 6/1/2027 +1 more

4 metrics

RSUs granted 20,000 units Restricted stock units granted 6/11/2026

Grant price $0.00 per unit Equity compensation grant, not open-market purchase

Vesting date 6/1/2027 100% of RSUs vest on this date

Post-transaction holdings 20,000 shares/units Direct ownership following the grant

Key Terms

restricted stock units ("RSUs"), equity incentive plan, change of control

3 terms

restricted stock units ("RSUs") financial

"The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

equity incentive plan financial

"RSUs granted 6/11/2026 under the Company's equity incentive plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

change of control financial

"Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan)."

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aclarion (ACON) disclose in this Form 4 for Stephen Deitsch?

Aclarion reported that director Stephen Deitsch received a grant of 20,000 restricted stock units (RSUs). The award is equity compensation, with each RSU representing a contingent right to one share of Aclarion common stock once it vests.

How many Aclarion (ACON) RSUs were granted to Stephen Deitsch and at what price?

Stephen Deitsch was granted 20,000 RSUs of Aclarion common stock at a reported price of $0.00 per unit. This indicates a compensation grant rather than an open-market purchase, and no cash was paid for the award itself.

When do Stephen Deitsch’s Aclarion (ACON) RSUs vest?

All of Stephen Deitsch’s 20,000 RSUs are scheduled to vest 100% on 6/1/2027. After vesting, each RSU converts into one share of Aclarion common stock, assuming the standard conditions of the company’s equity incentive plan are satisfied.

What happens to the Aclarion (ACON) RSUs if there is a change of control?

Any outstanding and unvested RSUs granted to Stephen Deitsch will accelerate and fully vest upon a change of control, as defined in Aclarion’s equity incentive plan. This means vesting would occur earlier if such a transaction takes place.

How many Aclarion (ACON) shares or units does Stephen Deitsch hold after this transaction?

Following this transaction, Stephen Deitsch is reported to hold 20,000 shares/units of Aclarion common stock directly. This figure reflects the newly granted RSUs as shown in the Form 4’s post-transaction ownership line.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Deitsch Stephen

(Last) (First) (Middle)

C/O ACLARION, INC.

8181 ARISTA PLACE, SUITE 100

(Street)

BROOFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aclarion, Inc. [ ACON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		20,000(1)(2)	A	$0.00	20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock.

2. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

	/s/ Stephen Deitsch	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)